An image from Graphite Bio's new corporate campaign illustrates its Cure ambitions
Graphite Bio debuts corporate brand campaign with ‘Cure’ aspirations, even years ahead of drug approval
It’s tough to stand out in the gene editing field, so Graphite Bio adopted an uncommon biotech tactic — marketing.
The clinical-stage biotech — founded during the …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
